ORCP.L vs. NVO
ORCP.L (Oracle Coalfields plc) and NVO (Novo Nordisk A/S) are both stocks. ORCP.L operates in Thermal Coal (Energy), while NVO operates in Drug Manufacturers - General (Healthcare). Over the past 10 years, ORCP.L returned -34.46%/yr vs 8.12%/yr for NVO. At a 0.03 correlation, their price movements are largely independent.
Performance
ORCP.L vs. NVO - Performance Comparison
Loading charts...
Different Trading Currencies
ORCP.L is traded in GBp, while NVO is traded in USD. To make them comparable, the NVO values have been converted to GBp using the latest available exchange rates.
Returns By Period
In the year-to-date period, ORCP.L achieves a 26.67% return, which is significantly higher than NVO's -10.29% return. Over the past 10 years, ORCP.L has underperformed NVO with an annualized return of -34.46%, while NVO has yielded a comparatively higher 8.12% annualized return.
ORCP.L
- 1D
- 0.00%
- 1M
- -13.32%
- YTD
- 26.67%
- 6M
- 35.71%
- 1Y
- 187.88%
- 3Y*
- -29.83%
- 5Y*
- -36.90%
- 10Y*
- -34.46%
NVO
- 1D
- -0.09%
- 1M
- -4.21%
- YTD
- -10.29%
- 6M
- -9.72%
- 1Y
- -41.75%
- 3Y*
- -17.29%
- 5Y*
- 3.99%
- 10Y*
- 8.12%
ORCP.L vs. NVO - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
ORCP.L Oracle Coalfields plc | 26.67% | 56.25% | -26.15% | -84.15% | -55.91% | -11.43% | -52.27% | 131.58% | -74.67% | -34.21% |
NVO Novo Nordisk A/S | -10.29% | -43.55% | -14.46% | 47.10% | 37.24% | 65.07% | 19.71% | 23.81% | -7.82% | 39.70% |
Correlation
The correlation between ORCP.L and NVO is 0.05, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.05 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.04 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.03 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.03 |
Correlation (All Time) Calculated using the full available price history since Apr 20, 2011 | 0.03 |
Fundamentals
ORCP.L:
£5.20M
NVO:
$195.21B
ORCP.L:
-£0.00
NVO:
DKK 27.42
ORCP.L:
0.78
NVO:
6.21
ORCP.L:
£0.00
NVO:
DKK 327.80B
ORCP.L:
-£171.00
NVO:
DKK 268.30B
ORCP.L:
-£1.17M
NVO:
DKK 181.54B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ORCP.L vs. NVO — Risk / Return Rank
ORCP.L
NVO
ORCP.L vs. NVO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Oracle Coalfields plc (ORCP.L) and Novo Nordisk A/S (NVO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| ORCP.L | NVO | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.92 | ||
| Sortino ratioReturn per unit of downside risk | +3.90 | ||
| Omega ratioGain probability vs. loss probability | 1.36 | 0.85 | +0.51 |
| Calmar ratioReturn relative to maximum drawdown | 3.72 | -0.80 | +4.52 |
| Martin ratioReturn relative to average drawdown | 6.20 | -1.18 | +7.38 |
Loading charts...
Drawdowns
ORCP.L vs. NVO - Drawdown Comparison
The maximum ORCP.L drawdown since its inception was -99.92%, which is greater than NVO's maximum drawdown of -75.79%. Use the drawdown chart below to compare losses from any high point for ORCP.L and NVO.
Loading charts...
Drawdown Indicators
| ORCP.L | NVO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.92% | -75.79% | -24.13% |
Max Drawdown (1Y)Largest decline over 1 year | -50.15% | -53.28% | +3.13% |
Max Drawdown (3Y)Largest decline over 3 years | -90.92% | -75.79% | -15.13% |
Max Drawdown (5Y)Largest decline over 5 years | -97.95% | -75.79% | -22.16% |
Max Drawdown (10Y)Largest decline over 10 years | -99.67% | -75.79% | -23.88% |
Current DrawdownCurrent decline from peak | -99.67% | -69.82% | -29.85% |
Average DrawdownAverage peak-to-trough decline | -89.55% | -11.97% | -77.58% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 30.16% | 36.79% | -6.63% |
Volatility
ORCP.L vs. NVO - Volatility Comparison
Oracle Coalfields plc (ORCP.L) has a higher volatility of 21.24% compared to Novo Nordisk A/S (NVO) at 10.14%. This indicates that ORCP.L's price experiences larger fluctuations and is considered to be riskier than NVO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ORCP.L | NVO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 21.24% | 10.14% | +11.10% |
Volatility (6M)Calculated over the trailing 6-month period | 96.10% | 37.12% | +58.98% |
Volatility (1Y)Calculated over the trailing 1-year period | 173.45% | 50.71% | +122.74% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 142.23% | 37.92% | +104.31% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 134.31% | 32.66% | +101.65% |
Dividends
ORCP.L vs. NVO - Dividend Comparison
ORCP.L has not paid dividends to shareholders, while NVO's dividend yield for the trailing twelve months is around 4.11%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
NVO Novo Nordisk A/S | 4.11% | 3.31% | 1.68% | 1.00% | 1.20% | 1.35% | 1.87% | 2.14% | 1.45% | 1.52% | 2.87% | 0.92% |
ORCP.L Oracle Coalfields plc | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
ORCP.L vs. NVO - Financials Comparison
This section allows you to compare key financial metrics between Oracle Coalfields plc and Novo Nordisk A/S. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
ORCP.L and NVO have a correlation of 0.05, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
Find the right allocation for ORCP.L and NVO
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer